We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 13, 2020

Peripheral Cytotoxic T Lymphocyte Predicts Progression-Free Survival in HER2-Positive Advanced Breast Cancer

The Breast

 

Additional Info

The Breast
Peripheral Cytotoxic T Lymphocyte Predicts First-Line Progression Free Survival in HER2-Positive Advanced Breast Cancer
Breast 2021 Feb 01;55(xx)7-15, X-R Liu, J-J Yu, G-H Song, et al

Further Reading